Enzalutamide in First Line Androgen Deprivation Therapy for Metastatic Prostate Cancer
about
Enzalutamide in First Line Androgen Deprivation Therapy for Metastatic Prostate Cancer
description
clinical trial
@en
klinisch onderzoek
@nl
name
Enzalutamide in First Line Androgen Deprivation Therapy for Metastatic Prostate Cancer
@en
type
label
Enzalutamide in First Line Androgen Deprivation Therapy for Metastatic Prostate Cancer
@en
prefLabel
Enzalutamide in First Line Androgen Deprivation Therapy for Metastatic Prostate Cancer
@en
P17
P1132
P1476
Randomised Phase 3 Trial of En ...... tatic Prostate Cancer: ENZAMET
@en
P1813
ENZAMET
@en
P3098
NCT02446405
P580
2014-03-01T00:00:00Z
P582
2020-09-01T00:00:00Z